Legend Biotechnology

Developer of cell therapy to treat cancer and infectious diseases

placeNanjing, Jiangsu, China calendar_todayFounded 2014 groups1,576 employees language legendbiotech.com

Social engagement

Social engagement: 163.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Hudson Bay Capital, RA Capital Management, Johnson & Johnson Innovation, Lilly Asia Ventures.

Investor typeCountShare
Venture capital117%
Private equity117%
Other / undisclosed467%

Recent activity

29 Jun 2026
Milestone
regulatory
23 Jun 2026
Event
European Hematology Association (EHA) 2026
16 Jun 2026
Event
Cell & Gene panel discussion on balancing quality, compliance, and operational strategy in an evolving manufacturing landscape
Coming soon